Anti-GCNT2 monoclonal antibody

Pre-made anti-GCNT2 monoclonal antibody(mab)-benchmark antibody for ELISA, affinity binding assay, drug discovery and mechanism of action (MOA) research

Target products collectionGo to GCNT2/GCNT2 products collection >>
(antibodies, antigen, VLP, mRNA, ORF viral vector, etc)


Product information

Catalog No.Product NameSpecies Reactivity
GM-Tg-hg-IP0892-Ab-1/ GM-Tg-hg-IP0892-Ab-2Anti-Human GCNT2 monoclonal antibodyHuman
GM-Tg-rg-IP0892-Ab-1/ GM-Tg-rg-IP0892-Ab-2Anti-Rat GCNT2 monoclonal antibodyRat
GM-Tg-mg-IP0892-Ab-1/ GM-Tg-mg-IP0892-Ab-2Anti-Mouse GCNT2 monoclonal antibodyMouse
GM-Tg-cynog-IP0892-Ab-1/ GM-Tg-cynog-IP0892-Ab-2Anti-Cynomolgus/ Rhesus macaque GCNT2 monoclonal antibodyCynomolgus/ Rhesus macaque
GM-Tg-felg-IP0892-Ab-1/ GM-Tg-felg-IP0892-Ab-2Anti-Feline GCNT2 monoclonal antibodyFeline
GM-Tg-cang-IP0892-Ab-1/ GM-Tg-cang-IP0892-Ab-2Anti-Canine GCNT2 monoclonal antibodyCanine
GM-Tg-bovg-IP0892-Ab-1/ GM-Tg-bovg-IP0892-Ab-2Anti-Bovine GCNT2 monoclonal antibodyBovine
GM-Tg-equg-IP0892-Ab-1/ GM-Tg-equg-IP0892-Ab-2Anti-Equine GCNT2 monoclonal antibodyEquine

Size: 1mg | 10mg | 100mg



Product Description

Catalog No.GM-Tg-hg-IP0892-Ab-1/ GM-Tg-hg-IP0892-Ab-2; GM-Tg-rg-IP0892-Ab-1/ GM-Tg-rg-IP0892-Ab-2;
GM-Tg-mg-IP0892-Ab-1/ GM-Tg-mg-IP0892-Ab-2; GM-Tg-cynog-IP0892-Ab-1/ GM-Tg-cynog-IP0892-Ab-2;
GM-Tg-felg-IP0892-Ab-1/ GM-Tg-felg-IP0892-Ab-2; GM-Tg-cang-IP0892-Ab-1/ GM-Tg-cang-IP0892-Ab-2;
GM-Tg-bovg-IP0892-Ab-1/ GM-Tg-bovg-IP0892-Ab-2; GM-Tg-equg-IP0892-Ab-1/ GM-Tg-equg-IP0892-Ab-2
Products NameAnti-GCNT2 monoclonal antibody
Formatmab
Target NameGCNT2
Protein Sub-locationIntrocelluar Protein
Category of antibody
Derivation (species)Mouse
CH1+2+3 Isotype
(Receptor identification)
IgG
Type of Light Chain (VD-LC)N/A
Expression platformMammalian Expression
Bioactivity validationBinding affinity is validated by ELISA with recombinant soluble protein antigen. The potency in neutralizing, inhibiting or blocking of the target protein is not detected.
TagFc
Products descriptionPre-made anti-GCNT2 monoclonal antibody(mab) is expressed by mammalian cell line as a benchmark antibody for cell culture, ELISA or other affinity binding assay or functional assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic)
Purity Purity: ≥95% (SDS-PAGE)
Application Biological drug disovery including cell culture, assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic) and mechanism of action (MOA) research.
Formulation & Reconstitution Lyophilized from GM's Protein Stability Buffer2 (PSB2,Confidential Ingredients) or PBS (pH7.4);
For PSB2, reconstituted with 0.9% sodium chloride;
For PBS, reconstituted with ddH2O.
Storage Store at -20℃ to -80℃ under sterile conditions. Avoid repeated freeze-thaw cycles.

Reference




    Data / case study


    Click to get more Data / Case study about the product.



    Associated products


    CategoryCat No.Products Name
    Target AntigenGM-Tg-g-IP0892-Ag-1Recombinant multi-species GNT2A/ GCNT2/ CCAT protein


    Target information

    Target IDGM-IP0892
    Target NameGCNT2
    Gene ID2651,14538,306860,697468,488215,101094925
    Gene Symbol and Synonyms5330430K10Rik,bA360O19.2,bA421M1.1,CCAT,CTRCT13,GCNT2,GCNT2C,GCNT5,Gcnt6,IGNT,IGnTA,IGnTB,IGnTC,II,NACGT1,NAGCT1,ULG3
    Uniprot AccessionQ8N0V5
    Uniprot Entry NameGNT2A_HUMAN
    Protein Sub-locationIntrocelluar Protein
    Category
    DiseaseN/A
    Gene EnsemblENSG00000111846
    Target ClassificationN/A

    The target: GCNT2, gene name: GCNT2, also named as CCAT, CTRCT13C, GCNT5, IGNT, II, NACGT1, NAGCT1, ULG3, bA360O19.2, bA421M1.1, GCNT2. This gene encodes the enzyme responsible for formation of the blood group I antigen. The i and I antigens are distinguished by linear and branched poly-N-acetyllactosaminoglycans, respectively. The encoded protein is the I-branching enzyme, a beta-1,6-N-acetylglucosaminyltransferase responsible for the conversion of fetal i antigen to adult I antigen in erythrocytes during embryonic development. Mutations in this gene have been associated with adult i blood group phenotype. Alternatively spliced transcript variants encoding different isoforms have been described. [provided by RefSeq, Jul 2008].



    About Gmab

    GDU
    GDU



    GMab, developed by GeneMedi, constitutes an advanced library of recombinant monoclonal antibodies, each meticulously designed to target specific molecular entities. Leveraging the sophisticated capabilities of GM’s Taurus™ and LIBRA™ platforms, GMab synthesizes antibodies characterized by high binding affinity, exceptional physicochemical stability, and optimal developability profiles.

    Through expression in mammalian cell lines, GMab has been established as a paradigmatic reference antibody. It holds significance in myriad domains of biological drug discovery, encompassing cellular cultivation, innovative assay methodologies, strategic animal model systematization, in-depth pharmacokinetic & pharmacodynamic (PK/PD) modeling, and intricate mechanism of action (MOA) investigations.